Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
7/5 14:32
Key PointsChief Strategy and Business Officer Atul Dandekar exercised and sold 7,500 shares of common stock for a transaction value of ~$190,000 on April 29, 2026....